Piramal Pharma Ltd Board to Meet April 28 for Consideration of FY and Q Results
Piramal Pharma Ltd announced that its Board of Directors will convene a meeting on Tuesday, April 28, 2026. The meeting is scheduled to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year that concluded on March 31, 2026.The company also provided an update regarding the trading window for its securities. The window, which had previously closed on Wednesday, April 1, 2026, will remain closed until Thursday, April 30, 2026, encompassing both days.
PPLPHARMA Stock Price Movement
Shares of Piramal Pharma Limited are edging higher to ₹148.4 as of 2:25 PM today, gaining 0.61% in live trading. The stock is showing robust activity, currently trading on a volume of 1.36 million shares so far today.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.